Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Mullen

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|July 27, 1999
Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study GroupE J Heathcote, S James, K D Mullen, et al.
Hepatology (Baltimore, Md.)|May 1, 1994
Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapyH S Conjeevaram, A Nagle, A Katz, et al.
Journal of the American Dietetic Association|September 1, 1997
Relationship of nutritional status to length of stay, hospital costs, and discharge status of patients hospitalized in the medicine serviceC S Chima, K Barco, M L Dewitt, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 17, 2003
Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based reviewK Ramasubbu, T Mullick, A Koo, et al.
Zeitschrift Fur Gastroenterologie|March 1, 1990
[Autoradiography determination of the GABA(A) receptor density in the brain of rats with portacaval shunt]M Rössle, J Deckert, K D Mullen, et al.
Gastroenterology|January 1, 1988
Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feedingA J McCullough, D Barron, K D Mullen, et al.
Alimentary Pharmacology & Therapeutics|February 11, 2011
Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statementJ S Bajaj, J Cordoba, K D Mullen, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 8, 2001
Use of subcutaneous venous access ports to treat refractory ascitesD I Rosenblum, M A Geisinger, J S Newman, et al.
Hepatology (Baltimore, Md.)|July 1, 1986
Leucine metabolism in stable cirrhosisK D Mullen, S C Denne, A J McCullough, et al.
Archives of Internal Medicine|September 1, 1987
Psychiatric complications of long-term interferon alfa therapyP F Renault, J H Hoofnagle, Y Park, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|July 27, 1999
Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study GroupE J Heathcote, S James, K D Mullen, et al.
Hepatology (Baltimore, Md.)|May 1, 1994
Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapyH S Conjeevaram, A Nagle, A Katz, et al.
Journal of the American Dietetic Association|September 1, 1997
Relationship of nutritional status to length of stay, hospital costs, and discharge status of patients hospitalized in the medicine serviceC S Chima, K Barco, M L Dewitt, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 17, 2003
Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based reviewK Ramasubbu, T Mullick, A Koo, et al.
Zeitschrift Fur Gastroenterologie|March 1, 1990
[Autoradiography determination of the GABA(A) receptor density in the brain of rats with portacaval shunt]M Rössle, J Deckert, K D Mullen, et al.
Gastroenterology|January 1, 1988
Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feedingA J McCullough, D Barron, K D Mullen, et al.
Alimentary Pharmacology & Therapeutics|February 11, 2011
Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statementJ S Bajaj, J Cordoba, K D Mullen, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 8, 2001
Use of subcutaneous venous access ports to treat refractory ascitesD I Rosenblum, M A Geisinger, J S Newman, et al.
Hepatology (Baltimore, Md.)|July 1, 1986
Leucine metabolism in stable cirrhosisK D Mullen, S C Denne, A J McCullough, et al.
Archives of Internal Medicine|September 1, 1987
Psychiatric complications of long-term interferon alfa therapyP F Renault, J H Hoofnagle, Y Park, et al.
Pageof 8